Dec 20(Reuters) - Harbin Gloria Pharmaceuticals Co Ltd
* Says it signs framework agreement to acquire 70 percent stake in a Shanghai-based information technology firm (target firm), at the tentative price of about 1.6 billion yuan
* Says target firm is mainly engaged in market service of bank card receipt business
* Says final acquisition price will be decided later
Source text in Chinese: goo.gl/eHu9i4
Further company coverage: (Beijing Headline News)
Our Standards: The Thomson Reuters Trust Principles.